Aline Massé

3.0k total citations
23 papers, 904 citations indexed

About

Aline Massé is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Aline Massé has authored 23 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 11 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in Aline Massé's work include Acute Myeloid Leukemia Research (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Multiple Myeloma Research and Treatments (4 papers). Aline Massé is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Multiple Myeloma Research and Treatments (4 papers). Aline Massé collaborates with scholars based in France, Australia and Uruguay. Aline Massé's co-authors include William Vainchenker, Nicole Casadevall, François Delhommeau, Sabrina Dupont, Patrick Saulnier, Najet Debili, Stéphane Giraudier, Jean‐Pierre Le Couedic, André Baruchel and Jeannig Berrou and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and Thrombosis and Haemostasis.

In The Last Decade

Aline Massé

23 papers receiving 885 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aline Massé France	10	581	502	419	168	80	23	904
Giuseppina Fugazza Italy	13	230 0.4×	330 0.7×	226 0.5×	83 0.5×	61 0.8×	36	599
Natasha Szuber Canada	16	504 0.9×	860 1.7×	894 2.1×	266 1.6×	49 0.6×	57	1.1k
Vincent Javaugue France	19	690 1.2×	300 0.6×	289 0.7×	81 0.5×	90 1.1×	39	938
F-X Mahon France	15	180 0.3×	496 1.0×	370 0.9×	230 1.4×	91 1.1×	26	682
Sébastien Bender France	16	552 1.0×	146 0.3×	181 0.4×	72 0.4×	106 1.3×	36	756
Carla B. Ripamonti Italy	14	452 0.8×	354 0.7×	146 0.3×	73 0.4×	89 1.1×	29	907
R M Baine United States	8	192 0.3×	285 0.6×	204 0.5×	30 0.2×	63 0.8×	14	510
Emmanuelle Verger France	15	299 0.5×	432 0.9×	468 1.1×	202 1.2×	80 1.0×	34	663
Jinlan Pan China	13	234 0.4×	369 0.7×	177 0.4×	43 0.3×	68 0.8×	104	603
Alberto Orfao Spain	13	118 0.2×	295 0.6×	138 0.3×	42 0.3×	65 0.8×	18	444

Countries citing papers authored by Aline Massé

Since Specialization

Citations

This map shows the geographic impact of Aline Massé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aline Massé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aline Massé more than expected).

Fields of papers citing papers by Aline Massé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aline Massé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aline Massé. The network helps show where Aline Massé may publish in the future.

Co-authorship network of co-authors of Aline Massé

This figure shows the co-authorship network connecting the top 25 collaborators of Aline Massé. A scholar is included among the top collaborators of Aline Massé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aline Massé. Aline Massé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Massé, Aline, Samuel Quentin, Ashwin Unnikrishnan, et al.. (2018). Granulomonocytic progenitors are key target cells of azacytidine in higher risk myelodysplastic syndromes and acute myeloid leukemia. Leukemia. 32(8). 1856–1860. 6 indexed citations

2.

Braun, Thorsten, Jeannig Berrou, Aline Massé, et al.. (2015). BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells. Oncotarget. 6(19). 17698–17712. 205 indexed citations

3.

Roulin, Louise, Aline Massé, Dominique Bluteau, et al.. (2015). Activity of OTX015 (MK-8628), a BET-Bromodomain Inhibitor, in Acute Myeloid Leukemia (AML) Progenitor Cells. Blood. 126(23). 2588–2588. 2 indexed citations

4.

Braun, Thorsten, Jeannig Berrou, Raphaël Itzykson, et al.. (2014). Bromodomain Inhibition By OTX015 Regulates c-MYC and HEXIM1 in a Panel of Human Acute Leukemia Cell Lines. Blood. 124(21). 5957–5957. 1 indexed citations

5.

Pronier, Elodie, Carole Almire, Aparna Vasanthakumar, et al.. (2011). Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors. Blood. 118(9). 2551–2555. 133 indexed citations

6.

Pronier, Elodie, Carole Almire, Bárbara da Costa Reis Monte-Mór, et al.. (2010). Inhibition of TET2 Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine Disturbs Myelopoiesis and Granulo-Monocytic Differentiation.. Blood. 116(21). 1584–1584. 3 indexed citations

7.

Delhommeau, François, Sabrina Dupont, Chloé James, et al.. (2008). TET2 Is a Novel Tumor Suppressor Gene Inactivated in Myeloproliferative Neoplasms: Identification of a Pre-JAK2 V617F Event. Blood. 112(11). lba–3. 17 indexed citations

8.

Kiladjian, Jean‐Jacques, Sabrina Dupont, Bruno Cassinat, et al.. (2008). Can Peg-Interferon (IFN) α-2a Eradicate JAK2V617F-Positive Bone Marrow Progenitors in Polycythemia Vera (PV)?. Blood. 112(11). 659–659. 2 indexed citations

9.

Dupont, Sabrina, Aline Massé, Chloé James, et al.. (2007). The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera. Blood. 110(3). 1013–1021. 143 indexed citations

10.

Delhommeau, François, Sabrina Dupont, Carole Tonetti, et al.. (2006). Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis. Blood. 109(1). 71–77. 119 indexed citations

11.

Pflumio, Françoise, Sophie Novault, Aline Massé, et al.. (2001). Efficient ex vivo expansion of NOD/SCID-repopulating cells with lympho-myeloid potential in hematopoietic grafts of children with solid tumors. The Hematology Journal. 2(2). 108–116. 8 indexed citations

12.

Letestu, Rémi, Natacha Vitrat, Aline Massé, et al.. (2000). Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome.. Blood. 95(5). 1633–41. 45 indexed citations

13.

Vitrat, Natacha, et al.. (2000). Thromboxane Synthase Has the Same Pattern of Expression as Platelet Specific Glycoproteins during Human Megakaryocyte Differentiation. Thrombosis and Haemostasis. 83(5). 759–768. 13 indexed citations

14.

Couedic, Jean‐Pierre Le, Isabelle Dusanter‐Fourt, Aline Massé, et al.. (1999). Autonomous Megakaryocyte Growth in Essential Thrombocythemia and Idiopathic Myelofibrosis Is Not Related to a c-mpl Mutation or to an Autocrine Stimulation by Mpl-L. Blood. 93(1). 125–139. 81 indexed citations

15.

Couedic, Jean‐Pierre Le, Isabelle Dusanter‐Fourt, Aline Massé, et al.. (1999). Autonomous Megakaryocyte Growth in Essential Thrombocythemia and Idiopathic Myelofibrosis Is Not Related to a c-mpl Mutation or to an Autocrine Stimulation by Mpl-L. Blood. 93(1). 125–139. 1 indexed citations

16.

Frindel, E, Aline Massé, P. Pradelles, Léonid Volkov, & Michel Rigaud. (1992). Correlation of endogenous acetyl-ser-asp-lys-pro plasma levels in mice and the kinetics of pluripotent hemopoietic stem cells entry into the cycle after cytosine arabinoside treatment: fundamental and clinical aspects.. PubMed. 6(6). 599–601. 8 indexed citations

17.

Frindel, E, Aline Massé, Léonid Volkov, C Lavignac, & Michel Rigaud. (1992). Inhibitory effects of AcSDKP on the mixed lymphocyte reaction (MLR). Part I. MLR with mouse spleen cells.. PubMed. 6(10). 1043–4. 2 indexed citations

18.

Lavignac, C, Léonid Volkov, Aline Massé, Michel Rigaud, & E Frindel. (1992). Inhibitory effects of AcSDKP on the mixed lymphocyte reaction (MLR). Part II. Human whole blood cells.. PubMed. 6(10). 1045–7. 2 indexed citations

19.

Pradelles, Philippe, Yveline Frobert, Christophe Créminon, et al.. (1990). Negative regulator of pluripotent hematopoietic stem cell proliferation in human white blood cells and plasma as analysed by enzyme immunoassay. Biochemical and Biophysical Research Communications. 170(3). 986–993. 72 indexed citations

20.

Massé, Aline, et al.. (1983). In vivo and in vitro study of regulatory effects caused by placental extracts. Journal of Reproductive Immunology. 5. 28–28. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact